A new trading day began on Monday, with Viridian Therapeutics Inc (NASDAQ: VRDN) stock price down -3.79% from the previous day of trading, before settling in for the closing price of $21.65. VRDN’s price has ranged from $9.90 to $27.20 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 31.28%. Meanwhile, its annual earnings per share averaged -9.88%. With a float of $73.55 million, this company’s outstanding shares have now reached $81.65 million.
Viridian Therapeutics Inc (VRDN) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Viridian Therapeutics Inc is 9.93%, while institutional ownership is 106.23%.
Viridian Therapeutics Inc (VRDN) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.15 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -9.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.51% during the next five years compared to 31.28% growth over the previous five years of trading.
Viridian Therapeutics Inc (NASDAQ: VRDN) Trading Performance Indicators
Here are Viridian Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5670.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.27, a number that is poised to hit -0.95 in the next quarter and is forecasted to reach -4.04 in one year’s time.
Technical Analysis of Viridian Therapeutics Inc (VRDN)
Looking closely at Viridian Therapeutics Inc (NASDAQ: VRDN), its last 5-days average volume was 0.65 million, which is a drop from its year-to-date volume of 0.87 million. As of the previous 9 days, the stock’s Stochastic %D was 76.36%.
During the past 100 days, Viridian Therapeutics Inc’s (VRDN) raw stochastic average was set at 88.31%, which indicates a significant increase from 66.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.93 in the past 14 days, which was higher than the 0.87 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.81, while its 200-day Moving Average is $16.49. However, in the short run, Viridian Therapeutics Inc’s stock first resistance to watch stands at $21.52. Second resistance stands at $22.22. The third major resistance level sits at $22.63. If the price goes on to break the first support level at $20.41, it is likely to go to the next support level at $20.00. Now, if the price goes above the second support level, the third support stands at $19.30.
Viridian Therapeutics Inc (NASDAQ: VRDN) Key Stats
With a market capitalization of 1.70 billion, the company has a total of 81,668K Shares Outstanding. Currently, annual sales are 300 K while annual income is -269,950 K. The company’s previous quarter sales were 80 K while its latest quarter income was -100,740 K.
